Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Standard
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. / Thol, Felicitas; Damm, Frederik; Lüdeking, Andrea; Winschel, Claudia; Wagner, Katharina; Morgan, Michael; Yun, Haiyang; Göhring, Gudrun; Schlegelberger, Brigitte; Hoelzer, Dieter; Lübbert, Michael; Kanz, Lothar; Fiedler, Walter; Kirchner, Hartmut; Heil, Gerhard; Krauter, Jürgen; Ganser, Arnold; Heuser, Michael.
in: J CLIN ONCOL, Jahrgang 29, Nr. 21, 21, 2011, S. 2889-2896.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
AU - Thol, Felicitas
AU - Damm, Frederik
AU - Lüdeking, Andrea
AU - Winschel, Claudia
AU - Wagner, Katharina
AU - Morgan, Michael
AU - Yun, Haiyang
AU - Göhring, Gudrun
AU - Schlegelberger, Brigitte
AU - Hoelzer, Dieter
AU - Lübbert, Michael
AU - Kanz, Lothar
AU - Fiedler, Walter
AU - Kirchner, Hartmut
AU - Heil, Gerhard
AU - Krauter, Jürgen
AU - Ganser, Arnold
AU - Heuser, Michael
PY - 2011
Y1 - 2011
N2 - To study the incidence and prognostic impact of mutations in DNA methyltransferase 3A (DNMT3A) in patients with acute myeloid leukemia.
AB - To study the incidence and prognostic impact of mutations in DNA methyltransferase 3A (DNMT3A) in patients with acute myeloid leukemia.
KW - Adult
KW - Germany
KW - Humans
KW - Middle Aged
KW - Risk Factors
KW - Adolescent
KW - Young Adult
KW - Treatment Outcome
KW - Age Factors
KW - Risk Assessment
KW - Survival Analysis
KW - Survival Rate
KW - Time Factors
KW - Disease-Free Survival
KW - Genetic Predisposition to Disease
KW - DNA Mutational Analysis
KW - Gene Expression Regulation, Leukemic
KW - DNA Methylation
KW - Tumor Markers, Biological/genetics/metabolism
KW - Mutation
KW - DNA (Cytosine-5-)-Methyltransferase/genetics/metabolism
KW - Leukemia, Myeloid, Acute/enzymology/genetics/mortality/therapy
KW - Adult
KW - Germany
KW - Humans
KW - Middle Aged
KW - Risk Factors
KW - Adolescent
KW - Young Adult
KW - Treatment Outcome
KW - Age Factors
KW - Risk Assessment
KW - Survival Analysis
KW - Survival Rate
KW - Time Factors
KW - Disease-Free Survival
KW - Genetic Predisposition to Disease
KW - DNA Mutational Analysis
KW - Gene Expression Regulation, Leukemic
KW - DNA Methylation
KW - Tumor Markers, Biological/genetics/metabolism
KW - Mutation
KW - DNA (Cytosine-5-)-Methyltransferase/genetics/metabolism
KW - Leukemia, Myeloid, Acute/enzymology/genetics/mortality/therapy
M3 - SCORING: Journal article
VL - 29
SP - 2889
EP - 2896
JO - J CLIN ONCOL
JF - J CLIN ONCOL
SN - 0732-183X
IS - 21
M1 - 21
ER -